Hypothesis

Hormetic stressors trigger a controlled release of nucleosomal cfDNA fragments that, when of sufficient length and carrying youthful methylation signatures, are taken up by stem/progenitor cells via TLR9‑dependent endocytosis. This uptake delivers epigenetic information that resets chromatin heterogeneity, counteracting age‑related cfDNA entropy rise. In contrast, chronic accumulation of short, hypomethylated cfDNA fragments from dying neutrophils fuels TLR9‑mediated inflammaging. Thus, the longevity benefit of hormesis depends on the balance between fragment size, methylation quality, and clearance efficiency.

Mechanistic Rationale

• Hormetic interventions (cold, fasting, exercise) cause transient, selective apoptosis of senescent neutrophils and colon epithelial cells, releasing cfDNA enriched for nucleosome‑protected ~150 bp fragments that retain promoter methylation of youth‑associated genes.Cell-free DNA methylation patterns and agingHeterochromatin-euchromatin cfDNA shift with age
• These fragments are recognized by TLR9 in the endosomes of mesenchymal stem cells, activating a MyD88‑IRF5 cascade that promotes histone acetyltransferase p300 recruitment to heterochromatin regions, reducing methylation entropy.Epigenetic entropy increases with age
• Simultaneously, hormesis upregulates serum DNase1L3 activity, preferentially degrading short (<100 bp) cfDNA that lack protective marks, preventing sustained TLR9 activation.cfDNA and TLR9 in inflammation
• When DNase1L3 is deficient or TLR9 is blocked, the same hormetic cfDNA shift fails to lower entropy and instead amplifies inflammatory cytokines, mirroring inflammaging.

Testable Predictions

1. In old mice, intraperitoneal injection of purified 150 bp cfDNA from young donor neutrophils will decrease cfDNA methylation entropy in blood and liver tissue after 2 weeks, an effect abolished by TLR9 antagonist ODN2088 or DNase1L3 knockout.
2. Hormetic interventions will increase the proportion of >120 bp cfDNA fragments in circulation; size‑shift will correlate with improved grip strength and reduced IL‑6 levels.
3. Supplementing old mice with recombinant DNase1L3 will mimic the epigenetic benefits of exercise, even without the stressor, by clearing inhibitory short cfDNA.

Experimental Approach

• Collect cfDNA from young (3 mo) and old (24 mo) mice; fractionate by size using SPRI beads.
• Perform whole‑genome bisulfite sequencing on each fraction to quantify methylation entropy.
• Treat old mice with size‑selected cfDNA ± TLR9 inhibitor ± DNase1L3 overexpression via AAV.
• Measure cfDNA concentration, fragment distribution, methylation entropy (using Shannon entropy of β‑values), serum cytokines, and functional phenotypes (rotarod, grip strength).

Potential Confounds

• cfDNA uptake may be cell‑type specific; we will control by using stem‑cell‑specific Cre reporters to track labeled cfDNA.
• Off‑target TLR9 activation by microbial DNA will be monitored via 16S rRNA qPCR.

Implications

If validated, this hypothesis reframes hormesis not as a vague “stress‑good” phenomenon but as a precise epigenetic information transfer mechanism, where the quality of danger signals—determined by fragment size, methylation pattern, and clearance—decides whether the cell interprets the cue as a threat to eliminate or a template to renew.